Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer

Category Primary study
Journalnpj Breast Cancer
Year 2022
This article has no abstract
Epistemonikos ID: b75aa7a7cd850510cd8ddde0b0ac2fcb3009ac26
First added on: Feb 14, 2025